by admin | Aug 26, 2020 | News
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, today announced that the United States Patent and Trademark Office (“USPTO”) yesterday issued U.S. Patent No. 10,752,663 with...
by admin | May 28, 2020 | News
NellOne Therapeutics Inc., the early stage biopharmaceutical company pioneering advances in regenerative medicine, will open a new research and development laboratory in Knox County, it was announced today. The facility will enable NellOne to add up to 20 new jobs...
by admin | May 18, 2020 | News
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, announced today the filing of a provisional patent application around the usage of the NELL1 signaling protein in the...
by admin | Apr 7, 2020 | News
NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, has appointed accomplished leader and entrepreneur William A. Malkes as its new Chief Executive Officer. NellOne Therapeutics...
